The evolution of drug regulatory sciences in the Netherlands: 15 years of follow-up
In the Netherlands drug regulatory science is a vibrant national and internationally oriented community. In this review we present the factors that have contributed to this successful collaboration between relevant stakeholders, and that led to a surge of activities around how regulatory science became embedded in the ecosystem of medicines research, clinical pharmacology, policy making and regulation. We distinguished three pivotal episodes: 1) TI Pharma Escher-project, 2) Dutch Medicines Evaluation Board as catalyst of the big jump, 3) Regulatory Science Network Netherlands and multistakehol... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | posted-content |
Erscheinungsdatum: | 2023 |
Verlag/Hrsg.: |
Authorea
Inc. |
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-26851666 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.22541/au.168210542.21403220/v1 |